Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Other Accumulated Expenses (2016 - 2024)

Bio Key International's Other Accumulated Expenses history spans 14 years, with the latest figure at $41021.0 for Q4 2024.

  • For Q4 2024, Other Accumulated Expenses fell 54.99% year-over-year to $41021.0; the TTM value through Dec 2024 reached $41021.0, down 54.99%, while the annual FY2024 figure was $41021.0, 54.99% down from the prior year.
  • Other Accumulated Expenses for Q4 2024 was $41021.0 at Bio Key International, down from $91136.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $91136.0 in Q4 2023 and bottomed at $3480.0 in Q4 2022.
  • The 5-year median for Other Accumulated Expenses is $41021.0 (2024), against an average of $41433.2.
  • The largest annual shift saw Other Accumulated Expenses tumbled 93.17% in 2022 before it soared 2518.85% in 2023.
  • A 5-year view of Other Accumulated Expenses shows it stood at $20548.0 in 2020, then soared by 148.11% to $50981.0 in 2021, then crashed by 93.17% to $3480.0 in 2022, then skyrocketed by 2518.85% to $91136.0 in 2023, then crashed by 54.99% to $41021.0 in 2024.
  • Per Business Quant, the three most recent readings for BKYI's Other Accumulated Expenses are $41021.0 (Q4 2024), $91136.0 (Q4 2023), and $3480.0 (Q4 2022).